China to lift most drug price controls in move aimed at safety, innovation
06 May 2015
Price controls on most drugs sold in China will be lifted in June, the National Development and Reform Commission (NDRC) said on Tuesday, a move signaled earlier by Beijing as a way to tackle issues of safety and to encourage innovation among domestic companies.
India, Europe talks on IP tussles break down
06 May 2015
India and a group of four European nations, including Switzerland, have broken off trade talks over a failure to resolve differences involving India's protections for intellectual property rights, particularly pharmaceuticals.
EMA Finds Scientific Advice Leads to Stronger Trial Design
06 May 2015
The European Medicines Agency (EMA) has released findings from its marketing authorization application analysis conducted between 2008 and 2012 by EMA’s Scientific Advice Working Party (SAWP). The findings, which were published in Nature Reviews Drug Discovery, state that companies that followed EMA recommendations for clinical development plans were more likely to be granted marketing authorization.
Biotech's boom spells a spike in R&D down payments
05 May 2015
The average upfront value in biotech deals hit a 9-year peak in 2014, according to Morrison & Foerster, part of a virtuous cycle in life sciences that has pushed asset valuations ever upward.
Research demonstrates how genome editing can eliminate mitochondrial mutations
05 May 2015
Researchers have used genome editing to selectively eliminate mitochondria mutations in the germline of mice, a technique they suggest could be applied to the treatment of mitochondrial diseases in humans.
Clearside Biomedical, Inc. and Santen, Inc. Announce Research Collaboration in Glaucoma
04 May 2015
Clearside Biomedical, Inc., a clinical-stage biopharmaceutical company developing first-in-class drug therapies to treat blinding diseases of the eye, and Santen Inc., a wholly owned subsidiary of Santen Pharmaceuticals Co., Ltd., today announced the expansion of their research collaboration to include the field of glaucoma.
02 May 2015
Atlas Genetics Ltd., developer of innovative, ultra-rapid diagnostics to enable a ‘test and treat’ solution to infectious diseases, today announces its Annual Summary for 2014.
Google's Calico continues its partnering romp on aging R&D with Buck collaboration
30 April 2015
Google's stealthy biotech Calico is setting up shop inside the Buck Institute for Research on Aging in Novato, CA, after hammering out the latest in a long lineup of deals to collaborate on a new generation of therapeutics.
Here's an M&A strategy: Buy products, hike prices, watch sales grow
29 April 2015
As the M&A wave sweeps over pharma, companies are wheeling and dealing for a number of different reasons. Slim-down strategies, tax break potential, portfolio diversification and other usual suspects have all driven transactions as of late--but the promise of price hikes has, too.
China hopes to learn ins and outs of regulation from U.S. FDA
29 April 2015
China's FDA is laying plans to work directly with its U.S. counterpart to learn the secrets of drug and medical-device regulation and bring China drugmaking and other regulated industries up to international standards.
06 September 2024
NovaMedica expands its line of products for the treatment of Alzheimer’s disease
22 August 2024
Children visited the NovaMedica Innotech pharmaceutical manufacturing facility
14 June 2024
87% of cancer patients give positive ratings for medical care quality
18 September 2024
The Russian market of fillers and biorevitalizers grew by 21% in the first half of 2024
18 September 2024
Pharma’s Patient Reach Problem: Billions Still Left Behind
17 September 2024
17 September 2024